ABCLAbCellera Biologics Inc.

ABCL Stock Price, Valuation & Chart | AbCellera Biologics Inc.

Compare

$11.360+0.08 (+0.71%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology ABCL intrinsic value ABCL calculated fair value vs price

Overview Financials Dividends Ratios

ABCL Historical price chart

ABCL Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization3.47B

PE Ratio-21.04

EPS-0.54

Trading Volume3.71M

Today's High/Low11.56/10.8

Dividend Yield0.00

52 Week High/Low12.58/2.75

Shares Outstanding305.38M

ABCL Financial Statement

ABCL Analyst ratings

ABCL Analysis & performance metrics

ABCL Company profile

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database…

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36…

ABCL Management team

Name

Position

Veronique Lecault Ph.D.CTO

Chief Technology Officer & Director

Marcie Thiessen CPA, CGACTO

Senior Director of Finance & Accounting

Tryn T. Stimart Esq., J.D., M.Sc.

Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer

Murray McCutcheon Ph.D.

Senior Vice President of Partnering

Tiffany Chiu B.Sc., Ph.D.

Vice President of Communications

Andrew Booth M.B.A.CFO

Chief Financial Officer

Graham Craig M.Sc.CTO

Director of Corporate Development

Neil Aubuchon B.A., M.B.A.

Chief Commercial Officer

Name

Position

Veronique Lecault Ph.D.CTO

Chief Technology Officer & Director

Marcie Thiessen CPA, CGACTO

Senior Director of Finance & Accounting

Tryn T. Stimart Esq., J.D., M.Sc.

Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer

Murray McCutcheon Ph.D.

Senior Vice President of Partnering

Tiffany Chiu B.Sc., Ph.D.

Vice President of Communications

Andrew Booth M.B.A.CFO

Chief Financial Officer

Graham Craig M.Sc.CTO

Director of Corporate Development

Neil Aubuchon B.A., M.B.A.

Chief Commercial Officer

Management Team

Veronique Lecault Ph.D.CTO

Chief Technology Officer & Director

Marcie Thiessen CPA, CGACTO

Senior Director of Finance & Accounting

Tryn T. Stimart Esq., J.D., M.Sc.

Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer

Murray McCutcheon Ph.D.

Senior Vice President of Partnering

Tiffany Chiu B.Sc., Ph.D.

Vice President of Communications

Andrew Booth M.B.A.CFO

Chief Financial Officer

Graham Craig M.Sc.CTO

Director of Corporate Development

Neil Aubuchon B.A., M.B.A.

Chief Commercial Officer

Management

Veronique Lecault Ph.D.CTO

Chief Technology Officer & Director

Marcie Thiessen CPA, CGACTO

Senior Director of Finance & Accounting

Tryn T. Stimart Esq., J.D., M.Sc.

Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer

Murray McCutcheon Ph.D.

Senior Vice President of Partnering

Tiffany Chiu B.Sc., Ph.D.

Vice President of Communications

Andrew Booth M.B.A.CFO

Chief Financial Officer

Graham Craig M.Sc.CTO

Director of Corporate Development

Neil Aubuchon B.A., M.B.A.

Chief Commercial Officer

Total 8 executives

ABCL Frequently asked questions

What is AbCellera Biologics Inc. (ABCL) Stock Price?

Current stock price of AbCellera Biologics Inc. (ABCL) stock is $11.360. The stock price is +0.71% higher in the session. The intraday range can be seen from this page. Volume of AbCellera Biologics Inc. (ABCL) stock is 3.71M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the AbCellera Biologics Inc. (ABCL) stock price going up or down today?

The stock price of AbCellera Biologics Inc. (ABCL) can change with earnings, company news, and overall market sentiment. AbCellera Biologics Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the AbCellera Biologics Inc. stock expensive at its current price?

Whether AbCellera Biologics Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ABCL on this page is -21.04. EPS on this page is -0.54. Compare those figures with peers and growth expectations before deciding if the current AbCellera Biologics Inc. price is justified.

How has the stock price of AbCellera Biologics Inc. (ABCL) performed historically?

Historical performance for AbCellera Biologics Inc. (ABCL) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ABCL reacted to past earnings and market events.

Should I buy AbCellera Biologics Inc. (ABCL) stock, at this price?

Buying AbCellera Biologics Inc. (ABCL) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.